NM_020547.3:c.160C>T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP5_Moderate

The NM_020547.3(AMHR2):​c.160C>T​(p.Arg54Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,613,622 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R54H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000018 ( 1 hom. )

Consequence

AMHR2
NM_020547.3 missense

Scores

5
9
5

Clinical Significance

Likely pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 3.86

Publications

3 publications found
Variant links:
Genes affected
AMHR2 (HGNC:465): (anti-Mullerian hormone receptor type 2) This gene encodes the receptor for the anti-Mullerian hormone (AMH) which, in addition to testosterone, results in male sex differentiation. AMH and testosterone are produced in the testes by different cells and have different effects. Testosterone promotes the development of male genitalia while the binding of AMH to the encoded receptor prevents the development of the mullerian ducts into uterus and Fallopian tubes. Mutations in this gene are associated with persistent Mullerian duct syndrome type II. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Sep 2009]
AMHR2 Gene-Disease associations (from GenCC):
  • persistent Mullerian duct syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PP5
Variant 12-53424398-C-T is Pathogenic according to our data. Variant chr12-53424398-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3366389.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AMHR2NM_020547.3 linkc.160C>T p.Arg54Cys missense_variant Exon 2 of 11 ENST00000257863.9 NP_065434.1 Q16671-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AMHR2ENST00000257863.9 linkc.160C>T p.Arg54Cys missense_variant Exon 2 of 11 1 NM_020547.3 ENSP00000257863.3 Q16671-1
AMHR2ENST00000379791.7 linkc.160C>T p.Arg54Cys missense_variant Exon 2 of 9 1 ENSP00000369117.3 Q16671-3
AMHR2ENST00000550311.5 linkc.160C>T p.Arg54Cys missense_variant Exon 2 of 11 1 ENSP00000446661.1 Q16671-2
AMHR2ENST00000553037.1 linkn.121C>T non_coding_transcript_exon_variant Exon 1 of 2 4

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152150
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000639
AC:
16
AN:
250270
AF XY:
0.0000960
show subpopulations
Gnomad AFR exome
AF:
0.0000622
Gnomad AMR exome
AF:
0.0000291
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000884
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000185
AC:
27
AN:
1461354
Hom.:
1
Cov.:
32
AF XY:
0.0000261
AC XY:
19
AN XY:
726980
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33470
American (AMR)
AF:
0.00
AC:
0
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26122
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.000255
AC:
22
AN:
86218
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53360
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5560
European-Non Finnish (NFE)
AF:
0.00000360
AC:
4
AN:
1111886
Other (OTH)
AF:
0.00
AC:
0
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152268
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41554
American (AMR)
AF:
0.0000654
AC:
1
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000819
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000824
AC:
10
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000594

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Persistent Mullerian duct syndrome Pathogenic:1
Aug 08, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: AMHR2 c.160C>T (p.Arg54Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 250270 control chromosomes in the gnomAD database, including 1 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in AMHR2 causing Persistent Mullerian duct syndrome, allowing no conclusion about variant significance. c.160C>T has been reported in the literature in the compound heterozygous state in at least 2 individuals affected with Persistent Mullerian duct syndrome (example, Imbeaud_1996, Tian_2022), including at least 1 individual carrying a pathogenic variant in trans. These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. In vitro experiments showed this variant prevented binding of the ligand protein (encoded by AMH) and also eliminated the activation of a target gene by AMH, suggesting the activation pathway is disrupted by this variant (example, Belville_2009). The following publications have been ascertained in the context of this evaluation (PMID: 19457927, 8872466, 34810374). No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as likely pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Pathogenic
0.37
CADD
Pathogenic
30
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.74
D;.;.
Eigen
Uncertain
0.39
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.89
D;D;D
M_CAP
Uncertain
0.20
D
MetaRNN
Uncertain
0.57
D;D;D
MetaSVM
Pathogenic
0.91
D
MutationAssessor
Benign
0.97
L;L;L
PhyloP100
3.9
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-2.2
N;N;N
REVEL
Pathogenic
0.73
Sift
Uncertain
0.024
D;T;D
Sift4G
Uncertain
0.0020
D;D;D
Polyphen
1.0
D;.;.
Vest4
0.69
MutPred
0.74
Gain of catalytic residue at R59 (P = 9e-04);Gain of catalytic residue at R59 (P = 9e-04);Gain of catalytic residue at R59 (P = 9e-04);
MVP
0.98
MPC
0.54
ClinPred
0.23
T
GERP RS
4.2
PromoterAI
0.011
Neutral
Varity_R
0.32
gMVP
0.48
Mutation Taster
=64/36
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs534999427; hg19: chr12-53818182; API